Surgery Partners (SGRY) Superinvestor holders
11 of the superinvestors we track hold Surgery Partners (SGRY) in their latest 13F filings, $352M in total.
Summary
The largest holder is Matthew Halbower (Pentwater Capital Management), with $195M, 1.6% of the portfolio.
In their latest quarter: 2 opened a new position, 3 added, 4 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Matthew Halbower Pentwater Capital Management |
Trimmed | 11,630,000 | $195M | 1.6% | Q2 2026 |
| Hersh Cohen ClearBridge Investments |
Trimmed | 3,823,179 | $64M | 0.1% | Q2 2026 |
| Tony Yoseloff Davidson Kempner Capital Management |
Held | 3,336,464 | $56M | 1.4% | Q2 2026 |
| Howard Marks Oaktree Capital Management |
New position | 862,588 | $14M | 0.4% | Q2 2026 |
| Man Group Man Group plc |
Trimmed | 697,552 | $12M | 0.0% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Trimmed | 153,926 | $3M | 0.0% | Q2 2026 |
| Brandon Haley Holocene Advisors |
Added | 136,328 | $2M | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
New position | 130,100 | $2M | 0.0% | Q2 2026 |
| Paul Marshall Marshall Wace |
Added | 95,362 | $2M | 0.0% | Q2 2026 |
| Louis Bacon Moore Capital Management |
Held | 50,000 | $840,000 | 0.0% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 46,155 | $775,404 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 11 |
| Q1 2026 | 12 |
| Q4 2025 | 9 |
| Q3 2025 | 11 |
| Q2 2025 | 11 |
| Q1 2025 | 10 |
| Q4 2024 | 12 |
| Q3 2024 | 11 |
Questions about Surgery Partners
Which superinvestors own Surgery Partners?
11 of the superinvestors we track hold Surgery Partners (SGRY) in their latest 13F filings, $352M in total. Matthew Halbower, Hersh Cohen, Tony Yoseloff, Howard Marks, Man Group, Paul Tudor Jones.
Who is the largest superinvestor holder of SGRY?
The largest holder is Matthew Halbower (Pentwater Capital Management), with $195M, 1.6% of the portfolio.
From Surgery Partners's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.